HealthEquity, Inc. (HQY)
NASDAQ: HQY · Real-Time Price · USD
81.32
+0.89 (1.11%)
Mar 4, 2026, 10:15 AM EST - Market open
HealthEquity Stock Forecast
Stock Price Forecast
The 15 analysts that cover HealthEquity stock have a consensus rating of "Buy" and an average price target of $116.53, which forecasts a 43.30% increase in the stock price over the next year. The lowest target is $89 and the highest is $129.
Price Target: $116.53 (+43.30%)
Analyst Consensus: Buy
Analyst Ratings
The average analyst rating for HealthEquity stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Sep '25 | Oct '25 | Nov '25 | Dec '25 | Jan '26 | Feb '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 5 | 5 | 5 | 4 | 4 | 4 |
| Buy | 9 | 9 | 8 | 9 | 9 | 9 |
| Hold | 1 | 1 | 2 | 2 | 1 | 1 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 1 | 1 |
| Total | 15 | 15 | 15 | 15 | 15 | 15 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Barclays | Barclays | Buy Maintains $118 → $110 | Buy | Maintains | $118 → $110 | +35.27% | Feb 18, 2026 |
| BTIG | BTIG | Strong Buy Maintains $130 → $110 | Strong Buy | Maintains | $130 → $110 | +35.27% | Feb 17, 2026 |
| Goldman Sachs | Goldman Sachs | Hold → Strong Sell Downgrades $89 | Hold → Strong Sell | Downgrades | $89 | +9.44% | Jan 9, 2026 |
| Keybanc | Keybanc | Buy Maintains $120 → $125 | Buy | Maintains | $120 → $125 | +53.71% | Jan 8, 2026 |
| Barclays | Barclays | Buy Initiates $118 | Buy | Initiates | $118 | +45.11% | Dec 9, 2025 |
Financial Forecast
Revenue This Year
1.32B
from 1.20B
Increased by 10.35%
Revenue Next Year
1.43B
from 1.32B
Increased by 7.63%
EPS This Year
3.99
from 1.09
Increased by 266.15%
EPS Next Year
4.62
from 3.99
Increased by 15.68%
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
| Revenue | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | 1.4B | 1.5B | |
| Avg | 1.3B | 1.4B | |
| Low | 1.3B | 1.4B |
Revenue Growth
| Revenue Growth | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | 15.4% | 13.1% | |
| Avg | 10.4% | 7.6% | |
| Low | 6.8% | 2.7% |
EPS Forecast
| EPS | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | 4.20 | 5.30 | |
| Avg | 3.99 | 4.62 | |
| Low | 3.84 | 4.25 |
EPS Growth
| EPS Growth | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | 285.3% | 32.7% | |
| Avg | 266.2% | 15.7% | |
| Low | 252.4% | 6.6% |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.